Prognostic Significance of Fcgr2B Expression for the Response of Dlbcl Patients to Rituximab or Obinutuzumab Treatment

AuthID
P-013-VTW
28
Author(s)
Nowicka, M
·
Hilton, LK
·
Ashton-Key, M
·
Hargreaves, CE
·
Lee, C
·
Carter, MJ
·
Beers, SA
·
Potter, KN
·
Bolen, CR
·
[+8]·
Vitolo, U
·
Martelli, M
·
Trneny, M
·
Rushton, CK
·
Slack, GW
·
Farinha, P
·
Strefford, JC
·
Oestergaard, MZ
·
Morin, RD
·
Cragg, MS
Document Type
Article
Year published
2021
Published
in Blood Advances, ISSN: 2473-9529
Volume: 5, Issue: 15, Pages: 2945-2957
Indexing
Publication Identifiers
Source Identifiers
ISSN: 2473-9529
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Nowicka, M;   2 Hilton, LK;   3 Ashton-Key, M;
4 Hargreaves, CE;   5 Lee, C;   6 Foxall, R;
7 Carter, MJ;   8 Beers, SA;   9 Potter, KN;
10 Bolen, CR;   11 Klein, C;   12 Knapp, A;
13 Mir, F;   14 Rose-Zerilli, M;   15 Burton, C;
16 Klapper, W;   17 Scott, DW;   18 Sehn, LH;
19 Vitolo, U;   20 Martelli, M;   21 Trneny, M;
22 Rushton, CK;   23 Slack, GW;   24 Farinha, P;
25 Strefford, JC;   26 Oestergaard, MZ;   27 Morin, RD;
28 Cragg, MS;